Novartis to buy GSK portfiolio of 22 new drugs
(AGI) Milan, June 16 - Over 25 new molecules are beingdeveloped to treat 10 neoplasia conditions. In fact, there willbe 22 new drugs to treat patients with cancer or haematologicaldisorders, around the world. Novartis has bought the treatmentsdeveloped by GlaxoSmithKline, thus acquiring a robust portfolioto help cancer patients. "This operation expands yet furtherNovartis' clinical development programmes for cancer treatment.Currently there are about 340 global clinical studies inprogress and over 25,000 patients recruited across the world.Newly acquired treatments include the ones for melanomas,kidney cancer and haematological disorders (thrombocytopenicpurpura, chronic lymphatic